SURAKSHA DIAGNOSTIC
Back to Balance Sheet
|
SURAKSHA DIAGNOSTIC Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹1.02 Cr | ₹0.77 Cr | ₹0.45 Cr | ₹0.31 Cr | ₹0.11 Cr |
What is the latest Long Term Provisions ratio of SURAKSHA DIAGNOSTIC ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹1.02 Cr |
Mar2024 | ₹0.77 Cr |
Mar2023 | ₹0.45 Cr |
Mar2022 | ₹0.31 Cr |
Mar2021 | ₹0.11 Cr |
How is Long Term Provisions of SURAKSHA DIAGNOSTIC Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹1.02 Cr | 32.56 | |
Mar2024 | ₹0.77 Cr | 70.95 | |
Mar2023 | ₹0.45 Cr | 45.02 | |
Mar2022 | ₹0.31 Cr | 182.73 | |
Mar2021 | ₹0.11 Cr | - |
Compare Long Term Provisions of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,647.7 Cr | 4.7% | 1% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹121,528.0 Cr | 2.4% | 2.6% | 39.8% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹113,951.0 Cr | 1.3% | 9.4% | 18.2% | Stock Analytics | |
FORTIS HEALTHCARE | ₹71,524.7 Cr | 1.6% | 17.1% | 82% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹37,742.4 Cr | 1.9% | -7% | 55.7% | Stock Analytics | |
GLOBAL HEALTH | ₹37,343.1 Cr | 1% | 7.7% | 27.4% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | 4.7% |
1% |
|
SENSEX | 1.8% |
-0.2% |
2% |
You may also like the below Video Courses